Applied Microbiology and Biotechnology

, Volume 88, Issue 2, pp 401–407 | Cite as

Antimicrobial properties of nitric oxide and its application in antimicrobial formulations and medical devices

  • Mitchell Lawrence Jones
  • Jorge Gabriel Ganopolsky
  • Alain Labbé
  • Christopher Wahl
  • Satya Prakash
Mini-Review

Abstract

This review describes the antimicrobial properties of nitric oxide (NO) and its application as an antimicrobial agent in different formulations and medical devices. We depict the eukaryotic biosynthesis of NO and its physiologic functions as a cell messenger and as an antimicrobial agent of the cell-mediated immune response. We analyze the antimicrobial activity of NO and the eukaryotic protective mechanisms against NO for the purpose of delineating the therapeutic NO dosage range required for an efficacious and safe antimicrobial activity. We also examine the role of NO produced by virulent bacteria in lessening the efficacy of traditional antimicrobials. In addition, we discuss the efficacy of NO in the healing of infected wounds, describing different NO-producing devices by category, analyzing therapeutic levels, duration of NO production, as well as commercial considerations. Finally, we provide current and future prospects for the design and use of NO-producing devices.

Keywords

Nitric oxide Antimicrobial Bactericidal Fungicidal Bacteria Infection Wound healing Patch Dressing Device 

References

  1. Adams LB, Hibbs JB Jr, Taintor RR, Krahenbuhl JL (1990) Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from l-arginine. J Immunol 144:2725–2729Google Scholar
  2. Alican I, Kubes P (1996) A critical role for nitric oxide in intestinal barrier function and dysfunction. Am J Physiol 270:G225–G237Google Scholar
  3. Anstead GM, Quinones-Nazario G, Lewis JS (2007) Treatment of infections caused by resistant Staphylococcus aureus. Meth Mol Biol 391:227–258CrossRefGoogle Scholar
  4. Anstey NM, Weinberg JB, Hassanali MY, Mwaikambo ED, Manyenga D, Misukonis MA, Arnelle DR, Hollis D, McDonald MI, Granger DL (1996) Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J Exp Med 184:557–567CrossRefGoogle Scholar
  5. Augusto O, Linares E, Giorgio S (1996) Possible roles of nitric oxide and peroxynitrite in murine leishmaniasis. Braz J Med Biol Res 29:853–862Google Scholar
  6. Benjamin N, Pattullo S, Weller R, Smith L, Ormerod A (1997) Wound licking and nitric oxide. Lancet 349:1776–1776CrossRefGoogle Scholar
  7. Bhide M (2006) Nitric oxide delivery from polymeric wound dressings. Dissertation, University of AkronGoogle Scholar
  8. Blackytny R, Jude E (2006) The molecular biology of chronic wounds and delayed healing in diabetes. Diabet Med 23:594–608CrossRefGoogle Scholar
  9. De Groote MA, Fang FC (1995) NO inhibitions: antimicrobial properties of nitric oxide. Clin Infect Dis 21(Suppl 2):S162–S165Google Scholar
  10. Doel JJ, Hector MP, Amirtham CV, Al-Anzan LA, Benjamin N, Allaker RP (2004) Protective effect of salivary nitrate and microbial nitrate reductase activity against caries. Eur J Oral Sci 112:424–428CrossRefGoogle Scholar
  11. Evans T, Carpenter A, Kinderman H, Cohen J (1993a) Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 41:77–81Google Scholar
  12. Evans TJ, Strivens E, Carpenter A, Cohen J (1993b) Differences in cytokine response and induction of nitric oxide synthase in endotoxin-resistant and endotoxin-sensitive mice after intravenous gram-negative infection. J Immunol 150:5033–5040Google Scholar
  13. Fang FC (1997) Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 99:2818–2825CrossRefGoogle Scholar
  14. Friedman AJ, Han G, Navati MS, Chacko M, Gunther L, Alfieri A, Friedman JM (2008) Sustained release nitric oxide releasing nanoparticles: characterization of a novel delivery platform based on nitrite containing hydrogel/glass composites. Nitric Oxide 19:12–20CrossRefGoogle Scholar
  15. Ghaffari A, Jalili R, Ghaffari M, Miller C, Ghahary A (2007) Efficacy of gaseous nitric oxide in the treatment of skin and soft tissue infections. Wound Repair Regen 15:368–377CrossRefGoogle Scholar
  16. Ghaffari A, Miller CC, McMullin B, Ghahary A (2006) Potential application of gaseous nitric oxide as a topical antimicrobial agent. Nitric Oxide 14:21–29CrossRefGoogle Scholar
  17. Gorwitz RJ (2008) A review of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Pediatr Infect Dis J 27:1–7CrossRefGoogle Scholar
  18. Gosselink MP, Darby M, Zimmerman DD, Gruss HJ, Schouten WR (2005) Treatment of chronic anal fissure by application of l-arginine gel: a phase II study in 15 patients. Dis Colon Rectum 48:832–837CrossRefGoogle Scholar
  19. Gribbe O, Gustafsson LE, Wiklund NP (2008) Transdermally administered nitric oxide by application of acidified nitrite increases blood flow in rat epigastric island skin flaps. Eur J Pharmacol 578:51–56CrossRefGoogle Scholar
  20. Gusarov I, Shatalin K, Starodubtseva M, Nudler E (2009) Endogenous nitric oxide protects bacteria against a wide spectrum of antibiotics. Science 325:1380–1384CrossRefGoogle Scholar
  21. Hardwick JB, Tucker AT, Wilks M, Johnston A, Benjamin N (2001) A novel method for the delivery of nitric oxide therapy to the skin of human subjects using a semi-permeable membrane. Clin Sci (Lond) 100:395–400CrossRefGoogle Scholar
  22. Hetrick EM, Shin JH, Stasko NA, Johnson CB, Wespe DA, Holmuhamedov E, Schoenfisch MH (2008) Bactericidal efficacy of nitric oxide-releasing silica nanoparticles. ACS Nano 2:235–246CrossRefGoogle Scholar
  23. Ischiropoulos H, al-Mehdi AB (1995) Peroxynitrite-mediated oxidative protein modifications. FEBS Lett 364:279–282CrossRefGoogle Scholar
  24. Jones ML, Ganopolsky JG, Labbe A, Prakash S (2010) A novel nitric oxide producing probiotic patch and its antimicrobial efficacy: preparation and in vitro analysis. Appl Microbiol Biotechnol 87:509–516CrossRefGoogle Scholar
  25. Juedes MJ, Wogan GN (1996) Peroxynitrite-induced mutation spectra of pSP189 following replication in bacteria and in human cells. Mutat Res 349:51–61Google Scholar
  26. Kampschreur MJ, Tan NC, Picioreanu C, Jetten MS, Schmidt I, van Loosdrecht MC (2006) Role of nitrogen oxides in the metabolism of ammonia-oxidizing bacteria. Biochem Soc Trans 34:179–181CrossRefGoogle Scholar
  27. Kawanishi M (1995) Nitric oxide inhibits Epstein–Barr virus DNA replication and activation of latent EBV. Intervirology 38:206–213Google Scholar
  28. Li Y, Lee PI (2010) Controlled nitric oxide delivery platform based on S-nitrosothiol conjugated interpolymer complexes for diabetic wound healing. Mol Pharm 7:254–266CrossRefGoogle Scholar
  29. Lundberg JO, Weitzberg E (2009) NO generation from inorganic nitrate and nitrite: role in physiology, nutrition and therapeutics. Arch Pharm Res 32:1119–1126CrossRefGoogle Scholar
  30. Lundberg JO, Weitzberg E, Gladwin MT (2008) The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 7:156–167CrossRefGoogle Scholar
  31. Mollace V, Salvemini D, Anggard E, Vane J (1990) Cultured astrocytoma cells inhibit platelet aggregation by releasing a nitric oxide-like factor. Biochem Biophys Res Commun 172:564–569CrossRefGoogle Scholar
  32. Morris RE, WHEATLEY PS, Buttler AR (2005) Zeolytes for delivery of nitric oxide. PCT/GB2004/002905Google Scholar
  33. Morris SL, Hansen JN (1981) Inhibition of Bacillus cereus spore outgrowth by covalent modification of a sulfhydryl group by nitrosothiol and iodoacetate. J Bacteriol 148:465–471Google Scholar
  34. Mulligan MS, Hevel JM, Marletta MA, Ward PA (1991) Tissue injury caused by deposition of immune complexes is l-arginine dependent. Proc Natl Acad Sci USA 88:6338–6342CrossRefGoogle Scholar
  35. Napoli C, Ignarro LJ (2009) Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases. Arch Pharm Res 32:1103–1108CrossRefGoogle Scholar
  36. Nordmann P, Naas T, Fortineau N, Poirel L (2007) Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010. Curr Opin Microbiol 10:436–440CrossRefGoogle Scholar
  37. Palmer RM, Ashton DS, Moncada S (1988) Vascular endothelial cells synthesize nitric oxide from l-arginine. Nature 333:664–666CrossRefGoogle Scholar
  38. Schwarz MA, Lazo JS, Yalowich JC, Allen WP, Whitmore M, Bergonia HA, Tzeng E, Billiar TR, Robbins PD, Lancaster JR Jr (1995) Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide. Proc Natl Acad Sci USA 92:4452–4456CrossRefGoogle Scholar
  39. Shabani M, Pulfer SK, Bulgrin JP, Smith DJ (1996) Enhancement of wound repair with a topically applied nitric oxide-releasing polymer. Wound Repair Regen 4:353–362CrossRefGoogle Scholar
  40. Sobko T, Huang L, Midtvedt T, Norin E, Gustafsson LE, Norman M, Jansson EA, Lundberg JO (2006) Generation of NO by probiotic bacteria in the gastrointestinal tract. Free Radic Biol Med 41:985–991CrossRefGoogle Scholar
  41. Sobko T, Reinders CI, Jansson E, Norin E, Midtvedt T, Lundberg JO (2005) Gastrointestinal bacteria generate nitric oxide from nitrate and nitrite. Nitric Oxide 13:272–278CrossRefGoogle Scholar
  42. Stenzler A and Miller C (2006) Device and method for treatment of wounds with nitric oxide. 11/021,109:1–21Google Scholar
  43. Vazquez-Torres A, Jones-Carson J, Balish E (1996) Peroxynitrite contributes to the candidacidal activity of nitric oxide-producing macrophages. Infect Immun 64:3127–3133Google Scholar
  44. Weller R, Pattullo S, Smith L, Golden M, Ormerod A, Benjamin N (1996) Nitric oxide is generated on the skin surface by reduction of sweat nitrate. J Invest Dermatol 107:327–331CrossRefGoogle Scholar
  45. Weller R, Price RJ, Ormerod AD, Benjamin N, Leifert C (2001) Antimicrobial effect of acidified nitrite on dermatophyte fungi, Candida and bacterial skin pathogens. J Appl Microbiol 90:648–652CrossRefGoogle Scholar
  46. Wheatley PS, Butler AR, Crane MS, Fox S, Xiao B, Rossi AG, Megson IL, Morris RE (2006) NO-releasing zeolites and their antithrombotic properties. J Am Chem Soc 128:502–509CrossRefGoogle Scholar
  47. Xu J, Verstraete W (2001) Evaluation of nitric oxide production by lactobacilli. Appl Microbiol Biotechnol 56:504–507CrossRefGoogle Scholar
  48. Zeina B, Banfield C, al-Assad S (1997) Topical glyceryl trinitrate: a possible treatment for cutaneous leishmaniasis. Clin Exp Dermatol 22:244–245CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Mitchell Lawrence Jones
    • 1
  • Jorge Gabriel Ganopolsky
    • 2
  • Alain Labbé
    • 2
  • Christopher Wahl
    • 2
  • Satya Prakash
    • 1
  1. 1.Biomedical Technology and Cell Therapy Research Laboratory, Department of Biomedical Engineering and Physiology, Artificial Cells and Organs Research Centre, Faculty of MedicineMcGill UniversityMontrealCanada
  2. 2.Micropharma LimitedMontrealCanada

Personalised recommendations